Procter & Gamble Health Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹382 Cr +17.5% YoYSee revenue, profit and what management said. You are viewing Q2 FY24.
P&

Procter & Gamble Health Ltd

Q2 FY24Pharmaceuticals & Biotechnology

Procter & Gamble Health Q2 FY24: Revenue ₹1230 Cr, PAT ₹229 Cr

Q2 FY24 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹305Cr
Net profit
₹66Cr
Margin
29%

Procter & Gamble Health Ltd Q2 FY24 key numbers

Revenue
Reported Profit After Tax (PAT): ₹229 crore.

As stated in Procter & Gamble Health Ltd's Q2 FY24 investor presentation · published 25 Sept 2026. Reported figures, not investment advice.

Based on Procter & Gamble Health Ltd's Q2 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹5,416
Market cap₹9.1K Cr
P/E27.4

The short version

Reported revenue: ₹1230 crore (page 17) - Reported Profit After Tax (PAT): ₹229 crore (page 17) - Volume figure: 1.6 lakh units deployed across India (page 13)

From Procter & Gamble Health Ltd's Q2 FY24 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Reported revenue: ₹1230 crore (page 17)
  • Reported Profit After Tax (PAT): ₹229 crore (page 17)
  • Volume figure: 1.6 lakh units deployed across India (page 13)

Profitability & Margins

See what Procter & Gamble Health Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Procter & Gamble Health Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Pharmaceuticals & Biotechnology

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2KRM Ayurveda
Rev 1Mar 1
3
Rev 1Mar 2
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Procter & Gamble Health Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Procter & Gamble Health Ltd said on order book & pipeline — free account, 30 seconds.

Procter & Gamble Health Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Procter & Gamble Health Ltd Q2 FY24 results — key figures

Procter & Gamble Health Ltd Q2 FY24 reported results vs year-ago quarter, ₹ crore
₹ CrQ2 FY24
Revenue305
Operating profit (EBITDA)89
Operating margin29%
Profit before tax88
Net profit (PAT)66
EPS (₹)39.50

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹382 Cr, net profit ₹112 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Pharmaceuticals & Biotechnology this season

  • Lincoln Pharmaceuticals (Q2 FY24)

    Revenue**: ₹6,435 crore, up 19% year-on-year. Key concall takeaways from Lincoln Pharmaceuticals Ltd's Q2 FY24 earnings call — and how it ranks against sector…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Procter & Gamble Health Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Procter & Gamble Health Ltd Q2 FY24 results?

Reported revenue: ₹1230 crore (page 17) - Reported Profit After Tax (PAT): ₹229 crore (page 17) - Volume figure: 1.6 lakh units deployed across India (page 13)

What is Procter & Gamble Health Ltd share price analysis?

Procter & Gamble Health Ltd currently shows a neutral. The stock trades at a P/E of 27.4 with a market cap of ₹9,135 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Procter & Gamble Health Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.